Skip to main content
SpringerLink
Log in

Development and Validation of a Stability-Indicating HPLC-DAD Method for the Determination of Canagliflozin and Metformin Simultaneously in Combination Dosage Form

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The purpose of this study was to develop and validate a rapid, simple, easy, and precise high-performance liquid chromatography (HPLC) method with diode array detector (DAD) for the simultaneous determination of canagliflozin (CGLN) and metformin (MTFN) in a combined dosage formulation. The chromatographic separation was achieved using a column type Zorbax-x Sβ-C18 (4.6 × 250 mm, 5 μm particle size). Mobile phase consisted of 0.05 M H3PO4, acetonitrile, and methanol in the 45:45:10 (v/v) ratio. The method was validated as per ICH guidelines in terms of system suitability, ranges, linearity, precision, specificity, accuracy, robustness, limit of quantification (LOQ) and limit of detection (LOD). The retention time (RT, tr) for MTFN and CGLN were obtained at 8 and 9.45 min, respectively. The calibration curves were found linear in the range of 5 – 100 μg/mL for both drugs in this study, with good correlation coefficients (R2 > 0.99898). The suggested design proved to be selective and stability-indicating by the resolution (Rs) of both analytes as well as by the study of forced-degradation (hydrolysis, oxidation, photolysis, and dry heat) products. The validated HPLC-DAD procedure was profitably tested for the analysis of CGLN and MTFN in their combination pharmaceutical tablet dosage form. In conclusion, a simple selective HPLC-DAD method has been successfully developed and validated for the determination of CGLN and MTFN simultaneously in pharmaceutical dosage form.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.

Similar content being viewed by others

References

  1. R. Awad, E. Mallah, I. Al-Ani, et al., J. Appl. Pharm. Sci., 6(10), 210 – 215 (2016).

    Article  CAS  Google Scholar 

  2. British Pharmacopoeia 2010. Her Majesty’s Stationery Office, London (2010). pp. 671 – 673, 686 – 687, 2606 – 2610, 2615.

  3. S. C. Sweetman, Martindale the Complete Drug Reference, 36th Edn. (2009), p. 44.

  4. The United States Pharmacopeia 2011 (USP 34)–The National Formulary (NF 29), The USP—NF Book (2010) [WorldCat.org], pp. 780 – 781, 2544 – 2549, 2564 – 2565.

  5. C. J. Bailey and R. C. Turner, N. Engl. J. Med., 334(9), 574 – 579 (1996).

    CAS  Google Scholar 

  6. S. Kiran and G. Saikiran, J. Pharm. Pharm Sci., 3(3), 1149 – 1159 (2014).

    Google Scholar 

  7. P. Nilam, P. Pinkal, and S. Khushbu, Int. J. Pharm. Sci. Res., 5(11), 4820 (2014).

    Google Scholar 

  8. I. Kaur, S. Wakode, and H. Pal Singh, Pharm. Methods, 6(2), 82 – 86 (2015).

    Article  CAS  Google Scholar 

  9. M. Iqbal, N. Y. Khalil, A. M. Alanazi, et al., Anal. Methods, 7(7), 3028 – 3035 (2015).

    Article  CAS  Google Scholar 

  10. I. Kaur, S. Wakode, and H. P. Singh, J. Appl. Pharm. Sci., 6(5), 51 – 57 (2016).

    Article  CAS  Google Scholar 

  11. M. Iqbal, E. Ezzeldin, K. A. Al-Rashood, et al., Talanta, 132, 29 – 36 (2015).

    Article  CAS  Google Scholar 

  12. U. P. Panigrahy and A. S. K. Reddy, Orient. J. Chem., 31(3), 1489 – 1507 (2015).

    Article  CAS  Google Scholar 

  13. D. Gaware, R. N. Patil, and M. Harole, World J. Pharm. Pharm. Sci., 4(12), 631 – 640 (2015).

    CAS  Google Scholar 

  14. Sonia D’Souza and M. Krishna, Curr. Trends Biotechnol. Pharm., 10(4), 334 – 342 (2016).

  15. N. P. Reddy and N. T. Chevela, Int. J. Pharm., 5(4), 1155 – 1159 (2015).

    Google Scholar 

  16. ICH Validation of Analytical Procedures, ICH Harmonised Tripatite Guidelines, Q2 B (1997), ICH OfficialWeb Site Available Online. https://www.ich.org/fileadmin/PublicWebSite/ICHProducts/Guidelines/Quality/Q2R1/Step4/Q2R1Guideline.pdf

  17. W. Abu Dayyih and M. Hamad, Indones. J. Pharm., 29(3), 117 – 126 (2018).

    Article  CAS  Google Scholar 

  18. S. A. Hamid, L. N. Tamimi, W. A. Dayyih, et al., J. Global Trends Pharm. Sci., 9(2): 5657 – 5670 (2018).

    CAS  Google Scholar 

  19. W. A. Dayyih, L. Tamimi, E. Mallah, et al., Int. J. Pharm. Pharm. Sci., 7(9), 243 – 250 (2019).

    Google Scholar 

  20. W. A. Dayyih, Z. Zulkifli, M. Hamad, et al., Int. J. Pharm. Sci. Res., 9(7), 2965 – 2972 (2018).

    CAS  Google Scholar 

  21. M. A. Khalil, A. Ghadir, I. Salama, et al., Int. J. Pharm. Chem. Biol. Sci., 8(1), 1 – 13 (2018).

    CAS  Google Scholar 

  22. W. A. Dayyih, R. Al-Shdefat, Z. Zakareia, et al., J. Pharm. Sci. Res., 11(8), 2934 – 2941 (2019).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Pharmacy, Jadara University, Irbid, Jordan

    Ramadan Al-Shdefat

  2. Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan

    Israa Al-Ani

  3. Faculty of Pharmacy and Medical Sciences, University of Petra, Amman, Jordan

    Lina Tamimi, Riad Awad, Walid Abu Rayyan & Wael Abu Dayyih

Authors
  1. Ramadan Al-Shdefat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Israa Al-Ani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lina Tamimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Riad Awad
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Walid Abu Rayyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wael Abu Dayyih
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wael Abu Dayyih.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Al-Shdefat, R., Al-Ani, I., Tamimi, L. et al. Development and Validation of a Stability-Indicating HPLC-DAD Method for the Determination of Canagliflozin and Metformin Simultaneously in Combination Dosage Form. Pharm Chem J 55, 402–409 (2021). https://doi.org/10.1007/s11094-021-02436-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-021-02436-7

Keywords

Search

Navigation